Spire Wealth Management - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$7,310
+0.8%
1000.0%0.00%
Q4 2023$7,252
+21.0%
1000.0%0.00%
Q3 2023$5,992
-16.9%
1000.0%0.00%
Q2 2023$7,210
-2.0%
1000.0%0.00%
Q1 2023$7,356
+635.6%
100
+900.0%
0.00%
Q2 2022$1,000
-90.9%
10
-90.0%
0.00%
Q1 2022$11,000
-26.7%
1000.0%0.00%
Q4 2021$15,000
+7.1%
1000.0%0.00%
Q3 2021$14,000
+7.7%
1000.0%0.00%
Q2 2021$13,000
-13.3%
1000.0%0.00%
Q1 2021$15,0001000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$25,673,00016.20%
Stonepine Capital Management, LLC 160,919$11,702,00012.38%
VILLERE ST DENIS J & CO LLC 635,758$46,232,0003.94%
CARDINAL CAPITAL MANAGEMENT LLC /CT 982,049$71,415,0003.51%
Elk Creek Partners, LLC 246,251$17,907,0003.08%
Tygh Capital Management, Inc. 151,792$11,038,0002.47%
Roubaix Capital, LLC 20,034$1,457,0002.21%
Conestoga Capital Advisors, LLC 648,603$47,166,0001.38%
RICE HALL JAMES & ASSOCIATES, LLC 338,376$24,607,0001.38%
Ikarian Capital, LLC 200,000$14,544,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders